Terumo Corp. Announces Acquisition of OrganOx Limited for $1.5 Billion

TOKYO — Terumo Corporation, a leading health care equipment and supply manufacturer based in Shibuya-Ku, Japan, has announced a definitive agreement to acquire OrganOx Limited, a pioneering company specializing in organ preservation devices. The acquisition, valued at approximately $1.5 billion, marks a strategic expansion for Terumo into the organ transplantation-related sector.

OrganOx, founded in 2008 by Professor Peter Friend and Professor Constantin Coussios as a spin-off from the University of Oxford, is renowned for its advanced organ preservation technologies, particularly Normothermic Machine Perfusion (NMP). These technologies are designed to extend the viability of organs by circulating oxygen and nutrient-rich perfusate through the organ at near-body temperature, while also enabling real-time monitoring of organ condition during storage and transport.

Upon completion of the transaction, OrganOx will become a wholly owned subsidiary of Terumo. This acquisition is expected to significantly enhance Terumo’s capabilities in the field of transplant medicine, providing expanded opportunities for organ transplantation worldwide.

The deal was announced on August 24, 2025, and is set to position Terumo as a key player in the rapidly evolving organ preservation market. Terumo, which is listed on the Tokyo Stock Exchange, has a market capitalization of approximately 4.06 trillion JPY and a price-to-earnings ratio of 32.41. The company’s shares closed at 2738.5 JPY on August 21, 2025.

This acquisition aligns with Terumo’s ongoing strategy to diversify its product offerings and strengthen its presence in the global health care market. Terumo markets a wide range of health-related products, including transfusion and infusion equipment, disposable medical supplies, clinical testing systems, artificial organs, and electronic thermometers, through its subsidiaries and sales offices in the US, Europe, and Asia.

The Japanese stock market reacted positively to the news, with the Nikkei 225 Index trading notably higher on Monday, extending gains from the previous session. Market heavyweights and technology stocks led the gains, contributing to a broader market uptrend.

For more information about Terumo Corporation and its offerings, visit www.terumo.com .